To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CDC16TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
544 supporting clones for gene CDC16 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_003903.3   .a 1 to 2211 1 to 2211 exact RefSeq, AAA   2211/2211
(100 %)
0 diff
(100 %id)
BX405021 B cells (Ramos cell line) .a 31 to 960 1 to 931   tiling clone,   931/931
(100 %)
5 diff
(99.5 %id)
BU947977 insulinoma, Pancreas .a 93 to 687 1 to 595   tiling clone,   595/595
(100 %)
4 diff
(99.4 %id)
AA081580   .a 131 to 739 1 to 598       598/601
(99 %)
15 diff
(97.6 %id)
BM691100 eye, RPE and Choroid .a 613 to 1316 1 to 705   tiling clone,   705/705
(100 %)
6 diff
(99.2 %id)
BU783466 insulinoma, Pancreas .a 900 to 1480 8 to 588   tiling clone,   581/588
(98 %)
6 diff
(99.0 %id)
W86111 liver and spleen .a 1192 to 1484 1 to 296       296/296
(100 %)
4 diff
(98.7 %id)
BX405020 B cells (Ramos cell line) .a 1205 to 2183 982 to 1   tiling clone,   982/982
(100 %)
24 diff
(97.6 %id)
TI_149288190   .a 1362 to 2211 929 to 88   AAA   842/978
(86 %)
22 diff
(97.8 %id)
TI_149314370   .a 1368 to 2211 916 to 83   AAA   834/961
(86 %)
15 diff
(98.5 %id)
TI_149308126   .a 1447 to 2211 849 to 87   AAA   763/943
(80 %)
10 diff
(99.0 %id)
AA887128 pooled germ cell tumors .a 1450 to 2211 771 to 12   AAA   760/979
(77 %)
25 diff
(97.5 %id)
BG207303   .a 1454 to 2202 755 to 9     Submitted on the opposite strand 747/827
(90 %)
24 diff
(97.1 %id)
CA309873 Alveolar Macrophage, lung .a 1485 to 2211 745 to 19   AAA   727/727
(100 %)
1 diff
(99.9 %id)
BU687000 lung, Primary Lung Epithelial Cells .a 1533 to 2211 696 to 19   AAA   678/678
(100 %)
5 diff
(99.3 %id)
AI660892 colon, colonic mucosa from 5 ulcerative colitispatients .a 1539 to 2211 682 to 14   AAA   669/669
(100 %)
6 diff
(99.2 %id)
CA419703 Bone, Human Chondrosarcoma Cell Line .a 1542 to 2211 688 to 19   AAA   670/670
(100 %)
1 diff
(99.9 %id)
CB306029 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1543 to 2211 687 to 19   AAA   669/669
(100 %)
1 diff
(99.9 %id)
BQ773702 Chondrosarcoma Grade II, Left Pelvis .a 1543 to 2211 687 to 19   tiling clone, AAA   669/669
(100 %)
0 diff
(100 %id)
BU630252 cell lines, Chondrosarcoma .a 1543 to 2211 687 to 19   AAA   669/669
(100 %)
1 diff
(99.9 %id)
BU681272 lung .a 1544 to 2211 686 to 19   AAA   668/668
(100 %)
1 diff
(99.9 %id)
AA489163 germinal center B cell .a 1549 to 2114 1 to 566       566/566
(100 %)
7 diff
(98.8 %id)
BQ774997 Bone, Human Chondrosarcoma Cell Line .a 1575 to 2211 655 to 19   AAA   637/660
(96 %)
0 diff
(100 %id)
BF055218 pooled .a 1578 to 2211 638 to 6       633/646
(97 %)
21 diff
(96.8 %id)
BU947705 insulinoma, Pancreas .a 1585 to 2205 620 to 1       620/620
(100 %)
1 diff
(99.9 %id)
AW662432 colon, moderately-differentiated adenocarcinoma .a 1594 to 2211 619 to 2       618/619
(99 %)
7 diff
(98.9 %id)
BQ774554 Chondrosarcoma Grade II, Left Pelvis .a 1602 to 2211 628 to 19   AAA   610/610
(100 %)
3 diff
(99.6 %id)
AW191052 adenocarcinoma, Pancreas .a 1607 to 2211 608 to 4       605/666
(90 %)
18 diff
(97.3 %id)
AI985830 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1624 to 2208 585 to 1       585/588
(99 %)
14 diff
(97.7 %id)
AI378643 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1626 to 2211 592 to 6       587/592
(99 %)
3 diff
(99.5 %id)
AW327421.
matches multiple genes
blood, T cell leukemia .a 1629 to 2208 584 to 6     Submitted on the opposite strand, also hits gene blorwee 579/584
(99 %)
0 diff
(100 %id)
AI634914 adenocarcinoma, Pancreas .a 1631 to 2211 581 to 1       581/582
(99 %)
2 diff
(99.7 %id)
AW778756 colon, moderately-differentiated adenocarcinoma .a 1636 to 2212 579 to 4       576/579
(99 %)
6 diff
(99.0 %id)
AA651773 germinal center B cell .a 1711 to 2211 523 to 24   AAA   500/509
(98 %)
24 diff
(95.3 %id)
AA847771 colon, colon tumor .a 1711 to 2185 474 to 1       474/474
(100 %)
9 diff
(98.2 %id)
AW316607 brain, three pooled meningiomas .a 1711 to 2211 501 to 1       501/507
(98 %)
4 diff
(99.3 %id)
BF791996 adrenal cortex carcinoma, cell line, adrenal gland .a 1711 to 2211 1 to 502   AAA   502/502
(100 %)
1 diff
(99.9 %id)
BU783216 insulinoma, Pancreas .a 1729 to 2211 483 to 1       483/483
(100 %)
1 diff
(99.8 %id)
AI282899 colon, moderately-differentiated adenocarcinoma .a 1741 to 2211 478 to 9       470/478
(98 %)
3 diff
(99.4 %id)
CB134440 Liver .a 1743 to 2211 1 to 469   AAA   469/469
(100 %)
3 diff
(99.4 %id)
AI278512 placenta .a 1744 to 2211 471 to 4       468/471
(99 %)
1 diff
(99.8 %id)
BQ004481 Chondrosarcoma, Left Pelvis .a 1758 to 2259 514 to 17       498/514
(96 %)
3 diff
(99.5 %id)
BM663581 eye, RPE and Choroid .a 1762 to 2257 513 to 18   tiling clone, AAA   496/496
(100 %)
0 diff
(100 %id)
AA084632   .a 1769 to 2210 444 to 1       444/444
(100 %)
4 diff
(99.1 %id)
AA972035 pooled .a 1771 to 2211 447 to 7       441/447
(98 %)
5 diff
(98.9 %id)
AW130961 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1825 to 2211 396 to 10       387/396
(97 %)
0 diff
(100 %id)
DB520997 testis .a 1827 to 2211 1 to 387   AAA Submitted on the opposite strand 387/387
(100 %)
23 diff
(94.1 %id)
W86112 liver and spleen .a 1834 to 2211 378 to 1       378/378
(100 %)
2 diff
(99.5 %id)
AA743472 germinal center B cell .a 1837 to 2211 394 to 24   AAA   371/371
(100 %)
8 diff
(97.9 %id)
AW779138 pooled .a 1853 to 2211 366 to 5       362/367
(98 %)
26 diff
(93.0 %id)
BU751729 placenta .a 1860 to 2211 369 to 18   AAA   352/352
(100 %)
1 diff
(99.8 %id)
AI270783 ovary, tumor, 5 pooled (see description) .a 1864 to 2211 347 to 2       346/353
(98 %)
5 diff
(98.6 %id)
AF006745   .a 1872 to 2211 333 to 1       333/333
(100 %)
9 diff
(97.3 %id)
CN401104 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1885 to 2257 1 to 373   AAA   373/373
(100 %)
0 diff
(100 %id)
T40845.
matches multiple genes
fetal spleen, Spleen .a 1888 to 2210 333 to 16   AAA also hits gene MED4 318/318
(100 %)
13 diff
(96.0 %id)
AW020064 cochlea, ear .a 1908 to 2211 1 to 304   AAA   304/304
(100 %)
5 diff
(98.4 %id)
T09435   .a 1937 to 2211 275 to 1       275/277
(99 %)
0 diff
(100 %id)
DB519986 testis .a 1974 to 2211 11 to 250     Submitted on the opposite strand 240/250
(96 %)
6 diff
(97.6 %id)
AI799896 Prostate .a 1990 to 2211 237 to 16   AAA   222/222
(100 %)
0 diff
(100 %id)
BF095769 uterus_tumor .a 2021 to 2189 172 to 5       168/172
(97 %)
1 diff
(99.5 %id)
GD158081   .a 2022 to 2211 1 to 189   AAA   189/189
(100 %)
2 diff
(99.0 %id)
CN401093 embryonic stem cells, DMSO-treated H9 cellline .a 2048 to 2211 1 to 164   AAA   164/164
(100 %)
0 diff
(100 %id)
AI304611 adenocarcinoma, colon .a 2084 to 2211 128 to 1       128/128
(100 %)
1 diff
(99.3 %id)
FN151453 breast carcinoma .a 2096 to 2202 1 to 103       103/103
(100 %)
4 diff
(96.2 %id)
FN143058 breast carcinoma .a 2109 to 2199 1 to 90       90/98
(91 %)
3 diff
(97.0 %id)
D25819   .a 2126 to 2211 1 to 86     Submitted on the opposite strand 86/89
(96 %)
1 diff
(98.9 %id)
DC391369 Spleen .b 1 to 569 1 to 569   tiling clone,   569/570
(99 %)
1 diff
(99.9 %id)
DC349220   .b 32 to 601 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DC323610 brain .b 40 to 637 1 to 598       598/598
(100 %)
1 diff
(99.9 %id)
BX367293   .b 43 to 1007 1 to 964       964/969
(99 %)
3 diff
(99.7 %id)
NM_001078645.1   .b 43 to 2335 1 to 2293 exact RefSeq, AAA   2293/2293
(100 %)
0 diff
(100 %id)
AL540490 placenta .b 47 to 969 1 to 924       924/924
(100 %)
3 diff
(99.7 %id)
DC343302 thalamus .b 53 to 581 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
DB454568 testis .b 53 to 525 1 to 473       473/473
(100 %)
0 diff
(100 %id)
DA885926   .b 54 to 594 2 to 544   capped   543/543
(100 %)
8 diff
(98.6 %id)
BU854992 ovary, teratocarcinoma, cell line .b 55 to 873 1 to 824       824/936
(88 %)
12 diff
(98.8 %id)
BQ277661 ovary, teratocarcinoma, cell line .b 61 to 780 22 to 745       724/1154
(62 %)
22 diff
(98.1 %id)
BI460653 testis .b 64 to 799 1 to 742       742/742
(100 %)
16 diff
(97.9 %id)
BU844376 ovary, teratocarcinoma, cell line .b 64 to 934 1 to 874       874/880
(99 %)
8 diff
(99.1 %id)
BU848968 ovary, teratocarcinoma, cell line .b 64 to 780 1 to 719       719/866
(83 %)
6 diff
(99.4 %id)
DB485288 hypothalamus .b 68 to 288 1 to 225       225/230
(97 %)
14 diff
(94.0 %id)
BG122313 adenocarcinoma, cell line, Liver .b 73 to 856 1 to 789       789/812
(97 %)
22 diff
(97.3 %id)
TI_57220904   .b 73 to 782 62 to 776       715/951
(75 %)
20 diff
(97.9 %id)
BI758309 brain .b 78 to 782 1 to 710       710/885
(80 %)
17 diff
(98.1 %id)
BQ639720 eye, retina .b 82 to 693 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
CN401102 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 91 to 804 12 to 725       714/725
(98 %)
10 diff
(98.7 %id)
ES308523 beard hair, skin .b 91 to 258 1 to 166       166/166
(100 %)
5 diff
(97.0 %id)
DN990912 brain, whole brain .b 91 to 778 7 to 694       688/694
(99 %)
10 diff
(98.6 %id)
BI602531 brain, hypothalamus .b 93 to 808 1 to 719       719/719
(100 %)
12 diff
(98.4 %id)
BI601685 brain, hypothalamus .b 93 to 870 1 to 785       785/959
(81 %)
17 diff
(98.3 %id)
AA223954   .b 98 to 480 1 to 386       386/387
(99 %)
8 diff
(98.0 %id)
TI_45213952   .b 98 to 808 153 to 866       712/866
(82 %)
13 diff
(98.5 %id)
TI_45214741   .b 98 to 870 126 to 905       780/1079
(72 %)
18 diff
(98.4 %id)
BP276385 Kidney .b 103 to 684 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA261441 caudate nucleus .b 104 to 638 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DA470910   .b 104 to 590 2 to 489   capped   488/490
(99 %)
5 diff
(99.0 %id)
DA702553   .b 104 to 585 2 to 484   capped   483/483
(100 %)
2 diff
(99.6 %id)
CD243371 testis .b 107 to 885 1 to 785       785/895
(87 %)
16 diff
(98.3 %id)
DA701906   .b 108 to 566 2 to 460   capped   459/459
(100 %)
1 diff
(99.8 %id)
DB025532 testis .b 108 to 655 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
DA553902   .b 114 to 660 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA024604   .b 131 to 693 11 to 577   capped   567/576
(98 %)
10 diff
(98.3 %id)
DA297896 hippocampus .b 131 to 684 13 to 569   capped   557/568
(98 %)
10 diff
(98.3 %id)
BG749151 eye, normal pigmented retinal epithelium .b 131 to 972 9 to 855       847/1115
(75 %)
35 diff
(96.9 %id)
BG750899 eye, normal pigmented retinal epithelium .b 131 to 868 9 to 752       744/849
(87 %)
20 diff
(97.7 %id)
BG752095 eye, normal pigmented retinal epithelium .b 131 to 943 9 to 820       812/834
(97 %)
23 diff
(97.3 %id)
BC017244 Skin, melanotic melanoma, high MDR. .b 133 to 2335 1 to 2203 exact available from MGC, AAA   2203/2203
(100 %)
6 diff
(99.8 %id)
AL513736 placenta .b 138 to 1186 1 to 1048       1048/1048
(100 %)
8 diff
(99.3 %id)
BG768289 melanotic melanoma, high MDR (cell line), skin .b 142 to 872 1 to 732       732/743
(98 %)
12 diff
(98.4 %id)
BQ948756 leiomyosarcoma, uterus .b 151 to 967 91 to 919       829/923
(89 %)
38 diff
(95.9 %id)
DA425373 colon .b 155 to 669 2 to 516   capped   515/515
(100 %)
4 diff
(99.3 %id)
BG766404 melanotic melanoma, high MDR (cell line), skin .b 158 to 876 1 to 728       728/770
(94 %)
29 diff
(96.3 %id)
CV812192 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 161 to 905 1 to 744       744/744
(100 %)
5 diff
(99.4 %id)
BM461627 eye, retinoblastoma .b 171 to 881 10 to 721       712/1107
(64 %)
20 diff
(98.2 %id)
DA473024   .b 181 to 732 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
DA983149 synovial membrane tissue from rheumatioidarthritis .b 182 to 736 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
CN401095 embryonic stem cells, cell lines H1, H7, andH9 .b 189 to 894 1 to 706       706/706
(100 %)
5 diff
(99.3 %id)
CN401100 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 191 to 804 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BP270080 small intestine .b 191 to 773 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP325838 prostata .b 191 to 773 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP325839 prostata .b 191 to 771 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
CN401099 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 195 to 621 1 to 428       428/430
(99 %)
7 diff
(98.4 %id)
CN401098 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 205 to 814 1 to 610       610/610
(100 %)
4 diff
(99.4 %id)
BP354504   .b 209 to 789 1 to 580       580/582
(99 %)
10 diff
(98.3 %id)
DA170997 amygdala .b 210 to 738 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
DA404690 thalamus .b 210 to 769 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB021550 testis .b 210 to 623 2 to 415   capped   414/414
(100 %)
0 diff
(100 %id)
DB027149 testis .b 210 to 764 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB045200 testis .b 211 to 770 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BP229133 brain .b 212 to 794 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
DB117569 thymus .b 212 to 764 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA848521 placenta .b 215 to 781 2 to 569   capped   568/570
(99 %)
5 diff
(99.2 %id)
CD358177 testis .b 220 to 967 1 to 752       752/851
(88 %)
15 diff
(98.3 %id)
BQ221870 melanotic melanoma, skin .b 226 to 1088 1 to 866       866/888
(97 %)
7 diff
(99.3 %id)
TI_1948242526   .b 240 to 1138 135 to 1032       898/1331
(67 %)
17 diff
(98.8 %id)
TI_1948242527   .b 240 to 1209 129 to 1098       970/1365
(71 %)
31 diff
(97.8 %id)
TI_1948242816   .b 240 to 1085 136 to 981       846/1393
(60 %)
16 diff
(98.9 %id)
TI_1948242817   .b 240 to 1209 132 to 1098       967/1354
(71 %)
31 diff
(97.8 %id)
TI_1948243102   .b 240 to 1087 134 to 980       847/1380
(61 %)
16 diff
(98.9 %id)
TI_1948243103   .b 240 to 1201 129 to 1089       923/1374
(67 %)
32 diff
(97.7 %id)
TI_1948243390   .b 240 to 1136 128 to 1019       892/1346
(66 %)
26 diff
(98.1 %id)
EL733570 mixed .b 241 to 872 1 to 631       631/658
(95 %)
9 diff
(98.7 %id)
CN401094 embryonic stem cells, DMSO-treated H9 cellline .b 243 to 1005 1 to 764       764/764
(100 %)
9 diff
(98.9 %id)
DA548604   .b 261 to 808 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
CT001179 T-Lymphocytes .b 264 to 910 8 to 661       654/661
(98 %)
13 diff
(98.1 %id)
BI831313 brain, medulla .b 266 to 985 1 to 722       722/726
(99 %)
9 diff
(98.8 %id)
TI_57176993   .b 266 to 985 72 to 793       722/797
(90 %)
14 diff
(98.3 %id)
DA178483 amygdala .b 278 to 830 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DA178511 amygdala .b 278 to 827 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DB041707 testis .b 278 to 833 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
CF785878 mixed .b 300 to 1007 8 to 712       705/787
(89 %)
14 diff
(98.3 %id)
BE926738 breast .b 342 to 670 329 to 1       329/331
(99 %)
19 diff
(94.3 %id)
AA362322   .b 344 to 703 1 to 367       367/370
(99 %)
11 diff
(97.1 %id)
N85707   .b 346 to 704 1 to 355       355/356
(99 %)
6 diff
(98.4 %id)
BM477396 lymph, lymphoma, cell line .b 358 to 1073 1 to 717       717/1099
(65 %)
14 diff
(98.8 %id)
AA746484 germinal center B cell .b 361 to 873 517 to 4       514/517
(99 %)
6 diff
(98.9 %id)
DA289657 hippocampus .b 363 to 925 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
BX641710   .b 382 to 649 1 to 268       268/268
(100 %)
0 diff
(100 %id)
AU123265   .b 385 to 948 2 to 566   capped   565/567
(99 %)
6 diff
(99.0 %id)
T31684 colon, embryo .b 386 to 849 1 to 486       412/486
(84 %)
17 diff
(96.6 %id)
FN111696 breast carcinoma .b 399 to 480 89 to 11     Submitted on the opposite strand 83/89
(93 %)
2 diff
(97.8 %id)
DA555763   .b 401 to 980 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
AA095225   .b 406 to 594 1 to 186       186/187
(99 %)
10 diff
(94.7 %id)
AI535837 Prostate .b 412 to 733 1 to 322     Submitted on the opposite strand 322/355
(90 %)
14 diff
(96.1 %id)
F06928 brain, total brain .b 416 to 779 1 to 364       364/364
(100 %)
2 diff
(99.5 %id)
BU182223 eye, retinoblastoma .b 421 to 1096 6 to 681       676/777
(87 %)
12 diff
(98.5 %id)
BQ304978 breast .b 424 to 567 153 to 10       144/153
(94 %)
1 diff
(99.4 %id)
BP292165 lung .b 438 to 1020 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
AA836498 germinal center B cell .b 448 to 873 429 to 4       426/431
(98 %)
3 diff
(99.4 %id)
BQ051608 blood, natural killer cells, cell line .b 449 to 1339 1 to 897       897/937
(95 %)
9 diff
(99.1 %id)
BU158464 large cell carcinoma, lung .b 451 to 1293 1 to 845       845/845
(100 %)
5 diff
(99.5 %id)
CF141557 CNCAP(3)T-225 cell line, Prostate .b 458 to 894 8 to 444       437/444
(98 %)
7 diff
(98.5 %id)
TI_154172305   .b 458 to 1004 91 to 641       551/1083
(50 %)
19 diff
(98.3 %id)
BF826708 head_normal .b 478 to 904 28 to 454       427/454
(94 %)
7 diff
(98.5 %id)
R61250 whole brain .b 486 to 950 1 to 467       467/474
(98 %)
20 diff
(95.8 %id)
AA135339 colon, tumor .b 488 to 799 1 to 312       312/312
(100 %)
0 diff
(100 %id)
BP327643 prostata .b 492 to 1074 1 to 581       581/581
(100 %)
13 diff
(97.8 %id)
TI_1948209326   .b 518 to 1280 132 to 897       766/1137
(67 %)
14 diff
(98.8 %id)
TI_1948209481   .b 518 to 1424 133 to 1047   tiling clone,   915/1166
(78 %)
29 diff
(97.6 %id)
TI_1948209638   .b 518 to 1317 131 to 930       800/1144
(69 %)
18 diff
(98.5 %id)
TI_1948209796   .b 518 to 1339 129 to 956       828/1051
(78 %)
28 diff
(97.4 %id)
EL734227 mixed .b 523 to 1233 1 to 707       709/708
(100 %)
6 diff
(99.2 %id)
T09436   .b 523 to 959 1 to 439       439/439
(100 %)
7 diff
(98.5 %id)
T09437   .b 523 to 868 1 to 346       346/346
(100 %)
3 diff
(99.2 %id)
AW953481   .b 524 to 1298 12 to 786       775/786
(98 %)
13 diff
(98.4 %id)
AW957173   .b 524 to 1159 22 to 658       637/659
(96 %)
16 diff
(97.6 %id)
CX785188 human embryonic stem cells .b 527 to 1087 1 to 561       561/579
(96 %)
0 diff
(100 %id)
AU137083 placenta .b 542 to 926 2 to 386   capped   385/385
(100 %)
1 diff
(99.8 %id)
BG122758 adenocarcinoma, cell line, Liver .b 575 to 1190 1 to 629       629/629
(100 %)
23 diff
(96.4 %id)
DB024748 testis .b 620 to 1178 2 to 563   capped   562/562
(100 %)
5 diff
(99.2 %id)
DA130070 alzheimer cortex .b 624 to 1253 2 to 631   capped   630/630
(100 %)
0 diff
(100 %id)
CX868678 embryonic stem .b 636 to 1415 1 to 780       780/780
(100 %)
0 diff
(100 %id)
CB150199 Liver .b 644 to 1332 1 to 689       689/689
(100 %)
2 diff
(99.8 %id)
AU119479 whole embryo, mainly head .b 656 to 1432 2 to 772   capped   771/771
(100 %)
9 diff
(98.9 %id)
BG751228 eye, normal pigmented retinal epithelium .b 689 to 1445 1 to 761       761/860
(88 %)
16 diff
(98.2 %id)
BG752198 eye, normal pigmented retinal epithelium .b 689 to 1490 1 to 802       802/805
(99 %)
14 diff
(98.3 %id)
BI118111 lung, small cell carcinoma .b 692 to 1339 1 to 651       651/1054
(61 %)
6 diff
(99.5 %id)
BQ882598 eye, normal pigmented retinal epithelium .b 692 to 1570 1 to 879       879/890
(98 %)
3 diff
(99.7 %id)
AI678178 Prostate .b 699 to 861 163 to 1       163/166
(98 %)
5 diff
(97.0 %id)
FN125845 breast carcinoma .b 772 to 877 107 to 1     Submitted on the opposite strand 107/107
(100 %)
1 diff
(99.1 %id)
DB057657 testis .b 788 to 1333 2 to 549   capped   548/548
(100 %)
3 diff
(99.5 %id)
CD245116 White Matter .b 794 to 1552 1 to 767       767/902
(85 %)
14 diff
(98.5 %id)
BE730106 melanotic melanoma, skin .b 806 to 1474 36 to 700       665/700
(95 %)
12 diff
(98.3 %id)
CN401101 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 817 to 1534 1 to 717       717/725
(98 %)
4 diff
(99.5 %id)
CN401103 embryonic stem cells, cell lines H1, H7, andH9 .b 821 to 1401 11 to 591       581/591
(98 %)
7 diff
(98.9 %id)
BI761697 pooled colon, kidney, stomach .b 821 to 1446 54 to 680       627/680
(92 %)
10 diff
(98.6 %id)
TI_57149225   .b 821 to 1446 90 to 716       627/716
(87 %)
10 diff
(98.7 %id)
FN097446 breast carcinoma .b 886 to 952 3 to 67       65/70
(92 %)
3 diff
(95.8 %id)
BP367463 thymus .b 889 to 1474 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
CB216245 normal endometrium, mid-secretory phase,cycle day 23, uterus .b 892 to 1497 1 to 606       606/606
(100 %)
0 diff
(100 %id)
CN401097 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 915 to 1549 1 to 635       635/635
(100 %)
3 diff
(99.6 %id)
AA304470 aorta .b 931 to 1338 1 to 407       407/407
(100 %)
1 diff
(99.8 %id)
AW605558 denis_drash .b 932 to 1204 282 to 10       273/282
(96 %)
2 diff
(99.3 %id)
EL954137 eyeball .b 943 to 1463 1 to 521       521/521
(100 %)
3 diff
(99.5 %id)
AA471106   .b 945 to 1171 1 to 226       226/226
(100 %)
9 diff
(96.1 %id)
CF142385 CNCAP(3)T-225 cell line, Prostate .b 947 to 1296 1 to 350       350/350
(100 %)
4 diff
(98.9 %id)
TI_154173394   .b 954 to 1487 78 to 616       539/668
(80 %)
12 diff
(98.3 %id)
FN172646 breast carcinoma .b 977 to 1083 1 to 107       107/107
(100 %)
0 diff
(100 %id)
CB128305 Liver .b 1008 to 1395 1 to 388       388/388
(100 %)
0 diff
(100 %id)
AW877439 pnet .b 1011 to 1211 32 to 228       197/243
(81 %)
11 diff
(95.5 %id)
AW877508 pnet .b 1012 to 1207 199 to 5       195/199
(97 %)
0 diff
(100 %id)
FN135855 breast carcinoma .b 1012 to 1094 1 to 84       84/91
(92 %)
9 diff
(90.2 %id)
BI255026 cervical carcinoma cell line, cervix .b 1015 to 1841 1 to 829       829/831
(99 %)
21 diff
(97.5 %id)
BF802140 colon_ins .b 1024 to 1425 411 to 11     Submitted on the opposite strand 401/411
(97 %)
0 diff
(100 %id)
AW630290 2 pooled high-grade transitional celltumors, genitourinary tract .b 1024 to 1451 1 to 428       428/429
(99 %)
5 diff
(98.9 %id)
AW363138 colon .b 1039 to 1652 13 to 626       614/626
(98 %)
8 diff
(98.8 %id)
TI_57239026   .b 1054 to 1820 34 to 799       766/801
(95 %)
11 diff
(98.7 %id)
BI916127 brain .b 1056 to 1820 1 to 764       764/766
(99 %)
6 diff
(99.3 %id)
CD245386 White Matter .b 1062 to 1922 1 to 862       862/867
(99 %)
6 diff
(99.4 %id)
W22696 eye, retina .b 1089 to 1528 443 to 5       439/667
(65 %)
10 diff
(98.6 %id)
FN132811 breast carcinoma .b 1092 to 1193 102 to 1     Submitted on the opposite strand 102/106
(96 %)
2 diff
(98.2 %id)
CN401096 embryonic stem cells, cell lines H1, H7, andH9 .b 1153 to 1896 1 to 744       744/744
(100 %)
4 diff
(99.5 %id)
BY796210 eye .b 1156 to 1749 1 to 594       594/594
(100 %)
0 diff
(100 %id)
AV743877 cord Blood .b 1189 to 1719 46 to 563       518/578
(89 %)
25 diff
(95.7 %id)
BX282171 melanotic melanoma, skin .b 1205 to 1690 1 to 486       486/486
(100 %)
0 diff
(100 %id)
CR747328 melanotic melanoma, skin .b 1205 to 1648 36 to 479       444/479
(92 %)
0 diff
(100 %id)
CR747461 melanotic melanoma, skin .b 1205 to 1684 36 to 515       480/515
(93 %)
0 diff
(100 %id)
AL046651 testis .b 1205 to 1919 1 to 715       715/715
(100 %)
1 diff
(99.9 %id)
BQ424567 melanotic melanoma, skin .b 1205 to 2035 24 to 863   tiling clone,   840/879
(95 %)
11 diff
(98.8 %id)
BF968912 adrenal cortex carcinoma, cell line, adrenal gland .b 1206 to 2003 1 to 830       825/904
(91 %)
102 diff
(88.8 %id)
TI_1948243104   .b 1206 to 2102 1025 to 130       896/1299
(68 %)
44 diff
(96.7 %id)
BE163237 head_neck .b 1222 to 1779 574 to 19     Submitted on the opposite strand 556/574
(96 %)
1 diff
(99.9 %id)
AA309741   .b 1248 to 1528 1 to 282       282/282
(100 %)
1 diff
(99.7 %id)
AW965729   .b 1249 to 1807 1 to 562       560/562
(99 %)
9 diff
(98.4 %id)
BX367292   .b 1252 to 2303 1048 to 1       1048/1048
(100 %)
5 diff
(99.6 %id)
BF351427 head_neck .b 1279 to 1831 7 to 560       558/560
(99 %)
32 diff
(94.3 %id)
BQ349848 head_neck .b 1279 to 1831 7 to 560       558/560
(99 %)
32 diff
(94.3 %id)
BG955633 colon .b 1294 to 1701 23 to 430       408/430
(94 %)
6 diff
(98.7 %id)
BG955640 colon .b 1294 to 1688 1 to 397       397/397
(100 %)
10 diff
(97.5 %id)
BQ668939 epidermoid carcinoma, cell line, salivary gland .b 1296 to 2197 1 to 909       909/920
(98 %)
22 diff
(97.7 %id)
BU151262 brain, neuroblastoma, cell line .b 1327 to 2140 1 to 823       823/909
(90 %)
22 diff
(97.6 %id)
AU185769 skin .b 1336 to 1903 568 to 1       568/611
(92 %)
7 diff
(98.9 %id)
AL540489 placenta .b 1336 to 2271 997 to 52   AAA   946/985
(96 %)
1 diff
(99.9 %id)
TI_1948209639   .b 1336 to 2105 879 to 107       773/1289
(59 %)
12 diff
(99.1 %id)
TI_1948209327   .b 1337 to 2102 886 to 120       767/1238
(61 %)
5 diff
(99.6 %id)
TI_1948242528   .b 1337 to 2102 895 to 129       767/1280
(59 %)
4 diff
(99.7 %id)
TI_1948242818   .b 1337 to 2102 894 to 128       767/1373
(55 %)
6 diff
(99.6 %id)
TI_1948243105   .b 1337 to 2102 894 to 123       772/1279
(60 %)
22 diff
(98.3 %id)
TI_1948243391   .b 1337 to 2102 897 to 124       774/1373
(56 %)
13 diff
(99.1 %id)
BM853744 Ascites, stomach .b 1355 to 1520 1 to 167       167/167
(100 %)
2 diff
(98.9 %id)
BF969962 adrenal cortex carcinoma, cell line, adrenal gland .b 1361 to 2175 1 to 806       806/938
(85 %)
34 diff
(96.4 %id)
BG484372 lung .b 1380 to 2128 1 to 761       761/762
(99 %)
40 diff
(94.8 %id)
BU079026 Pancreas, Purified pancreatic islet .b 1415 to 1983 11 to 579   fully sequenced,   569/579
(98 %)
7 diff
(98.8 %id)
AA096166   .b 1435 to 1622 1 to 191       191/219
(87 %)
6 diff
(97.3 %id)
TI_1948243392   .b 1437 to 2102 798 to 123       676/1326
(50 %)
17 diff
(98.8 %id)
R05407 liver and spleen .b 1451 to 1753 1 to 314       314/361
(86 %)
15 diff
(95.9 %id)
FN113199 breast carcinoma .b 1460 to 1543 12 to 96       85/96
(88 %)
7 diff
(92.8 %id)
AL513735 placenta .b 1476 to 2335 858 to 1       858/956
(89 %)
12 diff
(98.8 %id)
TI_149314081   .b 1481 to 2335 940 to 86   AAA   855/990
(86 %)
8 diff
(99.2 %id)
BC050575 Brain, hippocampus .b 1483 to 2335 700 to 1552   available from MGC, AAA   853/1552
(54 %)
0 diff
(100 %id)
TI_1948242819   .b 1491 to 2102 738 to 124       615/1433
(42 %)
7 diff
(99.6 %id)
BP203400 coronary artery .b 1528 to 2108 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
AA450274   .b 1532 to 1896 1 to 364       364/364
(100 %)
2 diff
(99.5 %id)
AI810866 Prostate .b 1553 to 2335 788 to 5       786/792
(99 %)
16 diff
(98.0 %id)
AW014305   .b 1553 to 1784 245 to 15       231/252
(91 %)
0 diff
(100 %id)
AI356260 B-cell, chronic lymphotic leukemia .b 1558 to 2335 779 to 3       779/779
(100 %)
13 diff
(98.4 %id)
TI_149300497   .b 1558 to 2335 873 to 101   AAA   773/957
(80 %)
12 diff
(98.8 %id)
BG998352 head_neck .b 1562 to 1973 1 to 412       412/412
(100 %)
9 diff
(97.9 %id)
CN401107 embryonic stem cells, DMSO-treated H9 cellline .b 1581 to 2260 9 to 688       680/688
(98 %)
8 diff
(98.9 %id)
CB243717 Human Lung Epithelial cells, lung .b 1583 to 2335 769 to 19   AAA   751/751
(100 %)
2 diff
(99.8 %id)
BM550250 melanotic melanoma, skin .b 1586 to 2332 1 to 746       746/840
(88 %)
3 diff
(99.7 %id)
BU633373 cell lines, Chondrosarcoma .b 1597 to 2335 756 to 19   AAA   738/738
(100 %)
1 diff
(99.9 %id)
BG258560 embryonal carcinoma, cell line, testis .b 1598 to 1910 1 to 312   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 312/323
(96 %)
2 diff
(99.4 %id)
TI_149306759   .b 1607 to 2381 857 to 86   AAA   772/897
(86 %)
13 diff
(98.6 %id)
AI417587 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1617 to 2335 720 to 2       719/731
(98 %)
21 diff
(97.2 %id)
TI_1948242529   .b 1617 to 2102 597 to 109       489/1267
(38 %)
19 diff
(98.6 %id)
CB305872 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1617 to 2335 737 to 19   AAA   719/742
(96 %)
0 diff
(100 %id)
R30772   .b 1621 to 1779 1 to 159       159/159
(100 %)
3 diff
(98.2 %id)
AA010054 liver and spleen .b 1625 to 1865 1 to 239       239/239
(100 %)
2 diff
(99.2 %id)
TI_151798033   .b 1627 to 2321 108 to 801       694/695
(99 %)
20 diff
(97.2 %id)
AI814188 adenocarcinoma, Pancreas .b 1632 to 2335 705 to 3       703/705
(99 %)
11 diff
(98.5 %id)
CA431348 cell lines, Enchondroma .b 1637 to 2335 716 to 19   AAA   698/698
(100 %)
1 diff
(99.9 %id)
AW799537 uterus .b 1639 to 1825 202 to 17       186/206
(90 %)
0 diff
(100 %id)
AI798731 pooled .b 1639 to 2335 698 to 4       695/698
(99 %)
5 diff
(99.3 %id)
BQ004159 Chondrosarcoma, Left Pelvis .b 1639 to 2335 714 to 19   AAA   696/700
(99 %)
1 diff
(99.9 %id)
AW892959 nervous_normal .b 1645 to 1906 271 to 11       261/271
(96 %)
0 diff
(100 %id)
AA436383 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1648 to 1910 1 to 263     Submitted on the opposite strand 263/264
(99 %)
4 diff
(98.5 %id)
AI828985 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 1654 to 2335 684 to 3       682/684
(99 %)
7 diff
(99.0 %id)
W46582 senescent fibroblast .b 1690 to 1988 1 to 301   fully sequenced,   301/301
(100 %)
2 diff
(99.4 %id)
BM976552 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1691 to 2335 663 to 19   AAA   645/645
(100 %)
0 diff
(100 %id)
BE167367 head_neck .b 1692 to 1970 287 to 9     Submitted on the opposite strand 279/287
(97 %)
0 diff
(100 %id)
AI435393 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1696 to 2335 643 to 5       639/643
(99 %)
2 diff
(99.7 %id)
AI908475 breast .b 1700 to 2324 13 to 637       625/671
(93 %)
13 diff
(98.1 %id)
FN059506 breast carcinoma .b 1703 to 1796 94 to 1     Submitted on the opposite strand 94/94
(100 %)
1 diff
(99.0 %id)
BM978822 lung, Primary Lung Epithelial Cells .b 1706 to 2381 691 to 19   AAA   673/673
(100 %)
4 diff
(99.5 %id)
FN076451 breast carcinoma .b 1709 to 1794 85 to 1     Submitted on the opposite strand 85/85
(100 %)
5 diff
(94.2 %id)
AI908474 breast .b 1710 to 2324 16 to 629       614/634
(96 %)
13 diff
(98.0 %id)
BF357508 head_neck .b 1725 to 2018 1 to 293       293/293
(100 %)
9 diff
(97.0 %id)
BQ574225 Chondrosarcoma Grade II, Left Pelvis .b 1726 to 2335 628 to 19   AAA   610/610
(100 %)
0 diff
(100 %id)
AI922537 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1744 to 2335 592 to 1       592/592
(100 %)
6 diff
(99.0 %id)
BG191838   .b 1750 to 2326 582 to 12     Submitted on the opposite strand 571/924
(61 %)
17 diff
(98.2 %id)
FN092037 breast carcinoma .b 1751 to 1838 1 to 89       89/94
(94 %)
8 diff
(91.5 %id)
AA666149 bone marrow stroma .b 1753 to 2332 579 to 1       579/585
(98 %)
13 diff
(97.8 %id)
BF057543 fibrotheoma, ovary .b 1753 to 2381 629 to 1       629/702
(89 %)
2 diff
(99.8 %id)
BE934796 head_neck .b 1757 to 2054 317 to 18       300/317
(94 %)
2 diff
(99.4 %id)
BM992862 lung, Metastatic Chondrosarcoma .b 1760 to 2335 594 to 19   AAA   576/578
(99 %)
1 diff
(99.9 %id)
FN098207 breast carcinoma .b 1767 to 1829 1 to 61       61/61
(100 %)
3 diff
(95.1 %id)
BU188594 melanotic melanoma, skin .b 1768 to 2335 4 to 571   AAA   568/571
(99 %)
5 diff
(99.2 %id)
CX868595 embryonic stem .b 1772 to 2335 590 to 27   AAA   564/564
(100 %)
4 diff
(99.3 %id)
BF435566 sciatic nerve .b 1774 to 2335 563 to 4       560/563
(99 %)
5 diff
(99.2 %id)
AI139994 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1775 to 2335 573 to 13   AAA   561/562
(99 %)
5 diff
(99.2 %id)
AI400305 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1780 to 2335 552 to 1       552/553
(99 %)
9 diff
(98.4 %id)
AI814450 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 1783 to 2335 555 to 3       553/555
(99 %)
0 diff
(100 %id)
BM988844 lung, Lung Focal Fibrosis .b 1791 to 2335 564 to 20   AAA   545/545
(100 %)
1 diff
(99.9 %id)
BG231567 blood, lymphocyte .b 1792 to 2098 307 to 1       307/307
(100 %)
14 diff
(95.5 %id)
AA328506   .b 1810 to 2173 1 to 367       367/367
(100 %)
3 diff
(99.2 %id)
AA993308   .b 1810 to 2335 528 to 4       525/528
(99 %)
2 diff
(99.7 %id)
EC552133 Prostate .b 1820 to 1919 98 to 1       98/98
(100 %)
2 diff
(98.0 %id)
EC561917 Prostate .b 1820 to 1919 98 to 1       98/98
(100 %)
2 diff
(98.0 %id)
AI082105 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1825 to 2335 510 to 1       510/510
(100 %)
4 diff
(99.3 %id)
BP393948 pancreatic islet .b 1830 to 2252 1 to 423     Submitted on the opposite strand 423/423
(100 %)
0 diff
(100 %id)
R65914 placenta .b 1831 to 2041 1 to 216   fully sequenced,   216/216
(100 %)
3 diff
(98.7 %id)
AU309859 neuroblastoma .b 1834 to 2335 524 to 23   AAA   502/502
(100 %)
0 diff
(100 %id)
AI923456 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1836 to 2335 502 to 3       500/599
(83 %)
0 diff
(100 %id)
AA919047 Kidney .b 1838 to 2335 498 to 1       498/501
(99 %)
6 diff
(98.9 %id)
DB357871 whole embryo, mainly head .b 1843 to 2335 492 to 1       492/524
(93 %)
16 diff
(97.0 %id)
AA481315 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1843 to 2335 494 to 1     Submitted on the opposite strand 494/518
(95 %)
14 diff
(97.3 %id)
DB376107 placenta .b 1843 to 2332 497 to 4       494/520
(95 %)
0 diff
(100 %id)
R62866 placenta .b 1844 to 2143 14 to 327   fully sequenced,   314/327
(96 %)
9 diff
(97.3 %id)
AA604798 adrenal adenoma, adrenal gland .b 1844 to 2334 492 to 1       492/492
(100 %)
5 diff
(99.0 %id)
AI033845 liver and spleen .b 1844 to 2335 495 to 2       494/510
(96 %)
0 diff
(100 %id)
AI201061   .b 1844 to 2335 496 to 4       493/496
(99 %)
0 diff
(100 %id)
BE350190 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .b 1845 to 2335 491 to 2       490/538
(91 %)
0 diff
(100 %id)
AA897517   .b 1846 to 2335 492 to 4       489/492
(99 %)
0 diff
(100 %id)
AA913045 pooled .b 1846 to 2335 498 to 10       489/498
(98 %)
0 diff
(100 %id)
AI091375 pooled .b 1846 to 2335 491 to 2       490/491
(99 %)
0 diff
(100 %id)
AI458274 pooled .b 1846 to 2335 490 to 2       489/490
(99 %)
0 diff
(100 %id)
AW662777 pooled .b 1846 to 2335 500 to 11   AAA   490/490
(100 %)
0 diff
(100 %id)
AA435757   .b 1849 to 2335 502 to 17   AAA   486/486
(100 %)
5 diff
(99.0 %id)
AI139740 uterus .b 1855 to 2335 490 to 10       481/490
(98 %)
0 diff
(100 %id)
BG192889   .b 1861 to 2139 32 to 310       279/310
(90 %)
9 diff
(97.1 %id)
AA223933   .b 1864 to 2335 474 to 1       474/474
(100 %)
3 diff
(99.4 %id)
AW194127 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1870 to 2335 484 to 14   AAA   471/471
(100 %)
26 diff
(94.5 %id)
AI081691 liver and spleen .b 1879 to 2335 456 to 1       456/456
(100 %)
10 diff
(97.9 %id)
AI440381 B-cell, chronic lymphotic leukemia .b 1882 to 2335 453 to 1       453/453
(100 %)
1 diff
(99.8 %id)
FN056037 breast carcinoma .b 1885 to 1966 1 to 82       82/82
(100 %)
1 diff
(98.8 %id)
AA588871 normal prostate, Prostate .b 1888 to 2335 476 to 30   AAA   447/447
(100 %)
4 diff
(99.2 %id)
AA284964 ovarian tumor, ovary .b 1891 to 2335 445 to 2       444/445
(99 %)
0 diff
(100 %id)
DB525587 testis .b 1892 to 2335 1 to 444     Submitted on the opposite strand 444/444
(100 %)
0 diff
(100 %id)
AA229114   .b 1894 to 2100 1 to 207       207/207
(100 %)
3 diff
(98.6 %id)
AA617635 lung, lung tumor .b 1894 to 2335 441 to 2       440/441
(99 %)
0 diff
(100 %id)
T87327 liver and spleen .b 1899 to 2335 451 to 2       450/453
(99 %)
0 diff
(100 %id)
DB531422 hippocampus .b 1903 to 2335 1 to 432     Submitted on the opposite strand 432/432
(100 %)
3 diff
(99.4 %id)
AI374851   .b 1903 to 2335 470 to 38   AAA   433/442
(97 %)
17 diff
(96.2 %id)
R05519 liver and spleen .b 1905 to 2317 428 to 1       428/451
(94 %)
20 diff
(95.6 %id)
AA010055 liver and spleen .b 1905 to 2335 439 to 1       439/439
(100 %)
10 diff
(97.8 %id)
AA468540 colon .b 1905 to 2335 427 to 1       427/429
(99 %)
7 diff
(98.4 %id)
AA135209 colon, tumor .b 1906 to 2083 187 to 10       178/187
(95 %)
0 diff
(100 %id)
AI056528 liver and spleen .b 1906 to 2335 430 to 1       430/430
(100 %)
0 diff
(100 %id)
AW054684 colon .b 1906 to 2335 430 to 1       430/430
(100 %)
8 diff
(98.2 %id)
R61251 whole brain .b 1916 to 2335 434 to 12   AAA   423/424
(99 %)
9 diff
(97.9 %id)
AA010234 liver and spleen .b 1922 to 2335 1 to 417       417/418
(99 %)
4 diff
(99.1 %id)
AA362321   .b 1924 to 2335 413 to 1       413/413
(100 %)
3 diff
(99.3 %id)
AA055380 heart .b 1924 to 2246 1 to 333       333/393
(84 %)
16 diff
(96.0 %id)
AA229050   .b 1925 to 2211 397 to 112       286/398
(71 %)
0 diff
(100 %id)
AI743524 pooled .b 1928 to 2335 415 to 8       408/415
(98 %)
0 diff
(100 %id)
AW780371 colon, moderately-differentiated adenocarcinoma .b 1933 to 2098 166 to 1       166/166
(100 %)
10 diff
(94.0 %id)
AI300391 carcinoid, lung .b 1938 to 2383 447 to 2   tiling clone,   446/447
(99 %)
0 diff
(100 %id)
AA365151 pineal body .b 1943 to 2273 1 to 332       332/332
(100 %)
2 diff
(99.4 %id)
TI_149281490   .b 1951 to 2335 489 to 105   AAA   385/765
(50 %)
1 diff
(99.9 %id)
BM983441 lung, Primary Lung Epithelial Cells .b 1951 to 2335 400 to 16   AAA   385/393
(97 %)
1 diff
(99.8 %id)
BU608458 Human Lung Epithelial cells, lung .b 1951 to 2335 400 to 16   AAA   385/394
(97 %)
1 diff
(99.8 %id)
AI858909 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1952 to 2335 404 to 21   AAA   384/385
(99 %)
10 diff
(97.5 %id)
BU078750 Pancreas, Purified pancreatic islet .b 1953 to 2335 383 to 1   fully sequenced,   383/383
(100 %)
0 diff
(100 %id)
BF838477 head_neck .b 1954 to 2277 339 to 17     Submitted on the opposite strand 323/342
(94 %)
0 diff
(100 %id)
W46583 senescent fibroblast .b 1958 to 2335 386 to 1   fully sequenced,   386/386
(100 %)
11 diff
(97.2 %id)
AI468750 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1963 to 2335 376 to 4       373/376
(99 %)
0 diff
(100 %id)
AI279055 carcinoid, lung .b 1964 to 2335 381 to 10       372/381
(97 %)
0 diff
(100 %id)
BE174220 head_neck .b 1965 to 2247 294 to 13     Submitted on the opposite strand 282/308
(91 %)
8 diff
(97.5 %id)
AW952989   .b 1967 to 2335 1 to 369       369/514
(71 %)
1 diff
(99.9 %id)
T32579 gallbladder .b 1967 to 2156 1 to 190       190/190
(100 %)
0 diff
(100 %id)
AI697726 carcinoid, lung .b 1970 to 2383 415 to 2       414/415
(99 %)
0 diff
(100 %id)
AI350568   .b 1971 to 2335 360 to 1       360/362
(99 %)
10 diff
(97.3 %id)
AA701427 liver and spleen .b 1975 to 2335 365 to 5       361/365
(98 %)
0 diff
(100 %id)
T56475.
matches multiple genes
fetal spleen, Spleen .b 1976 to 2335 382 to 12   AAA also hits gene HMGN3 371/371
(100 %)
15 diff
(96.0 %id)
AA450275   .b 1980 to 2335 356 to 1       356/356
(100 %)
0 diff
(100 %id)
FN175248 breast carcinoma .b 1986 to 2092 1 to 106       106/106
(100 %)
2 diff
(98.2 %id)
AW801981 uterus .b 1992 to 2322 332 to 1       332/334
(99 %)
2 diff
(99.5 %id)
BF334023 colon .b 2000 to 2176 178 to 2       177/178
(99 %)
0 diff
(100 %id)
Z40005 brain, total brain .b 2007 to 2335 331 to 1       331/331
(100 %)
2 diff
(99.4 %id)
FN095896 breast carcinoma .b 2011 to 2105 95 to 1     Submitted on the opposite strand 95/95
(100 %)
0 diff
(100 %id)
R65815 placenta .b 2011 to 2342 341 to 1   fully sequenced,   341/341
(100 %)
12 diff
(96.5 %id)
AI572551 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2042 to 2335 333 to 39   AAA   295/295
(100 %)
14 diff
(95.3 %id)
FN112475 breast carcinoma .b 2049 to 2109 61 to 1     Submitted on the opposite strand 61/65
(93 %)
0 diff
(100 %id)
AI291070 carcinoid, lung .b 2049 to 2334 286 to 1       286/286
(100 %)
0 diff
(100 %id)
BM670644 eye, fetal eyes .b 2060 to 2335 294 to 19   AAA   276/276
(100 %)
0 diff
(100 %id)
EH345234   .b 2064 to 2131 1 to 68       68/68
(100 %)
0 diff
(100 %id)
AA523317 metastatic prostate bone lesion .b 2064 to 2335 274 to 4       271/281
(96 %)
0 diff
(100 %id)
AL043053 testis .b 2072 to 2335 54 to 317   AAA   264/317
(83 %)
6 diff
(98.2 %id)
FN161249 breast carcinoma .b 2074 to 2146 1 to 74       74/74
(100 %)
2 diff
(97.3 %id)
BG941368 blood .b 2099 to 2335 277 to 41   AAA   237/237
(100 %)
2 diff
(99.2 %id)
FN048922 breast carcinoma .b 2112 to 2217 1 to 106       106/106
(100 %)
0 diff
(100 %id)
R62815 placenta .b 2119 to 2341 231 to 1   fully sequenced,   231/231
(100 %)
6 diff
(97.5 %id)
FN072162 breast carcinoma .b 2140 to 2218 1 to 80       80/80
(100 %)
3 diff
(96.3 %id)
EC573416 Prostate .b 2151 to 2245 21 to 115       95/115
(82 %)
6 diff
(94.8 %id)
DR977929 brain .b 2167 to 2335 1 to 168   AAA Submitted on the opposite strand 168/168
(100 %)
5 diff
(97.1 %id)
BU153346 embryonal carcinoma, cell line, testis .b 2183 to 2335 1 to 153   AAA   153/153
(100 %)
0 diff
(100 %id)
DA197736 brain .c 1 to 433 2 to 440   tiling clone, capped   439/439
(100 %)
4 diff
(99.1 %id)
DA769582 brain .c 1 to 583 2 to 585   tiling clone, capped   584/584
(100 %)
1 diff
(99.9 %id)
BI602490 brain, hypothalamus .c 11 to 816 1 to 821       820/848
(96 %)
41 diff
(95.2 %id)
TI_45213911   .c 14 to 816 149 to 966       817/993
(82 %)
42 diff
(95.8 %id)
DB443936 testis .c 33 to 477 1 to 450       450/450
(100 %)
12 diff
(97.4 %id)
AK315302   .c 156 to 2047 1 to 1892 E437G tiling clone,   1892/1892
(100 %)
1 diff
(100.0 %id)
DA650986   .c 157 to 698 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
U18291 brain .c 164 to 2197 1 to 2034 K137Q tiling clone,   2034/2034
(100 %)
4 diff
(99.9 %id)
AA397641   .c 274 to 535 1 to 262       262/265
(98 %)
9 diff
(96.7 %id)
AF164598   .d 1 to 1943 1 to 1942 P299L tiling clone,   1942/1942
(100 %)
7 diff
(99.7 %id)
AL546635 placenta, Placenta Cot 25-normalized .e 236 to 958 252 to 961   tiling clone,   961/961
(100 %)
21 diff
(97.9 %id)
AL546601 placenta, Placenta Cot 25-normalized .e 1288 to 2313 1023 to 1   tiling clone,   1023/1027
(99 %)
6 diff
(99.5 %id)
AA534681 colon .e 1686 to 1956 271 to 1       271/271
(100 %)
0 diff
(100 %id)
DA602026   .f 1 to 569 2 to 570   tiling clone, capped   569/569
(100 %)
1 diff
(99.9 %id)
AL557368 T cells (Jurkat cell line), T cells from T cell leukemia .f 4 to 974 16 to 980   tiling clone,   965/984
(98 %)
16 diff
(98.4 %id)
BE867107 adenocarcinoma, colon .f 22 to 730 1 to 707       707/709
(99 %)
13 diff
(98.2 %id)
BE407434 choriocarcinoma, placenta .f 87 to 746 1 to 659       659/686
(96 %)
7 diff
(99.0 %id)
BE384463 melanotic melanoma, skin .f 137 to 761 1 to 625       625/660
(94 %)
16 diff
(97.6 %id)
BQ944893 carcinoma, cell line, Prostate .f 138 to 979 1 to 843   tiling clone,   843/964
(87 %)
12 diff
(98.8 %id)
AL579414 T cells (Jurkat cell line), T cells from T cell leukemia .f 1228 to 2035 893 to 72   tiling clone,   839/893
(93 %)
58 diff
(93.6 %id)
BC010875 Lung, large cell carcinoma .g 1 to 2155 1 to 2155 exact tiling clone, available from MGC, AAA   2155/2155
(100 %)
0 diff
(100 %id)
BE789118 large cell carcinoma, lung .g 11 to 604 1 to 596       596/596
(100 %)
2 diff
(99.7 %id)
CN401105 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 134 to 303 1 to 170       170/170
(100 %)
0 diff
(100 %id)
DA015818 adrenal gland .h 1 to 565 2 to 567   tiling clone, capped   566/566
(100 %)
2 diff
(99.7 %id)
DA523524 brain .h 397 to 972 2 to 577   tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
DA829243 placenta .h 552 to 1233 2 to 685   capped   684/754
(90 %)
5 diff
(99.4 %id)
BJ989429 hepatoblastoma .h 568 to 1161 6 to 600   tiling clone,   595/600
(99 %)
6 diff
(99.0 %id)
CR626847 fetal brain .h 988 to 2466 1 to 1479 exact tiling clone,   1479/1479
(100 %)
0 diff
(100 %id)
AL537153 brain, fetal brain .h 988 to 1821 1 to 835   fully sequenced,   835/835
(100 %)
1 diff
(99.9 %id)
AL537152 brain, fetal brain .h 1760 to 2440 707 to 28   fully sequenced,   680/707
(96 %)
5 diff
(99.3 %id)
BJ989430 hepatoblastoma .h 1950 to 2489 540 to 1       540/540
(100 %)
0 diff
(100 %id)
DB317338 brain .h 1991 to 2509 521 to 1   tiling clone,   521/521
(100 %)
2 diff
(99.7 %id)
DB373979 placenta .h 2136 to 2509 374 to 1       374/374
(100 %)
11 diff
(97.1 %id)
AA284349 germinal center B cell .i 1 to 413 2 to 414   tiling clone,   414/414
(100 %)
0 diff
(100 %id)
AA284350 germinal center B cell .i 981 to 1378 397 to 1   tiling clone,   397/397
(100 %)
3 diff
(99.3 %id)
BX422399 fetal liver, Liver .j 1 to 919 1 to 918   tiling clone,   918/918
(100 %)
4 diff
(99.6 %id)
DB044715 testis .j 15 to 549 2 to 539   tiling clone, capped   538/538
(100 %)
4 diff
(99.3 %id)
BM548966 melanotic melanoma, skin .j 531 to 1433 1 to 904   tiling clone,   904/1100
(82 %)
16 diff
(98.6 %id)
AA410559 ovarian tumor, ovary .j 1403 to 1664 1 to 273   tiling clone, fully sequenced,   273/273
(100 %)
0 diff
(100 %id)
BX436168 fetal liver, Liver .j 1576 to 1928 355 to 1       355/432
(82 %)
23 diff
(94.7 %id)
AA410604 ovarian tumor, ovary .j 1634 to 1930 302 to 1   tiling clone, fully sequenced,   302/302
(100 %)
0 diff
(100 %id)
AA424001   .k 1 to 546 1 to 546   tiling clone,   546/546
(100 %)
4 diff
(99.3 %id)
BQ009960 Chondrosarcoma, Left Pubic Bone .k 603 to 1338 752 to 19   tiling clone, AAA   734/734
(100 %)
5 diff
(99.4 %id)
AA424002   .k 823 to 1338 519 to 5       515/519
(99 %)
6 diff
(98.9 %id)
R65616 placenta .l 1 to 383 1 to 390   tiling clone,   390/393
(99 %)
8 diff
(98.0 %id)
BU078191 Pancreas, Purified pancreatic islet .l 42 to 262 1 to 221   fully sequenced,   221/221
(100 %)
1 diff
(99.6 %id)
BU077860 Pancreas, Purified pancreatic islet .l 161 to 745 585 to 1       585/585
(100 %)
0 diff
(100 %id)
AV745126 Pituitary .l 166 to 758 1 to 593       593/625
(94 %)
22 diff
(96.5 %id)
AV752032 Pituitary .l 177 to 756 1 to 581   tiling clone,   581/862
(67 %)
7 diff
(99.2 %id)
AV751320 Pituitary .l 178 to 759 1 to 582       582/811
(71 %)
7 diff
(99.2 %id)
AI769683 2 pooled tumors (clear cell type), Kidney .l 190 to 746 557 to 1   tiling clone,   557/557
(100 %)
0 diff
(100 %id)
BU077946 Pancreas, Purified pancreatic islet .l 232 to 744 513 to 1   fully sequenced,   513/513
(100 %)
0 diff
(100 %id)
CA776816 Pancreas, Purified pancreatic islet .l 232 to 744 513 to 1       513/513
(100 %)
0 diff
(100 %id)
BQ773917 Chondrosarcoma Grade II, Left Pelvis .l 299 to 745 463 to 18   AAA   446/446
(100 %)
1 diff
(99.8 %id)
BQ022737 placenta .l 323 to 745 441 to 19   AAA   423/423
(100 %)
2 diff
(99.6 %id)
AA831369 germinal center B cell .l 345 to 754 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AI249031 liver and spleen .l 350 to 745 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
BM991103 lung, Lung Focal Fibrosis .l 404 to 745 360 to 19   AAA   342/342
(100 %)
0 diff
(100 %id)
R66998 placenta .l 408 to 744 352 to 1       352/402
(87 %)
20 diff
(95.1 %id)
AA906480 pooled .l 474 to 747 274 to 1       274/274
(100 %)
0 diff
(100 %id)
DA454706 tongue, tumor tissue .l 684 to 1246 2 to 565   tiling clone, capped   564/564
(100 %)
2 diff
(99.7 %id)
BP369287 testis .l 825 to 1397 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
DA391400 thalamus .l 946 to 1520 2 to 577   tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
AA887122 pooled germ cell tumors .l 1367 to 2329 978 to 13   tiling clone, AAA   966/1024
(94 %)
43 diff
(95.9 %id)
BU931379 ovary, teratocarcinoma, cell line .m 1 to 791 8 to 806   tiling clone,   799/840
(95 %)
14 diff
(98.4 %id)
BQ956932 brain, neuroblastoma, cell line .m 642 to 1475 1 to 834   tiling clone,   834/841
(99 %)
2 diff
(99.8 %id)
BU597414 mixed (pool of 40 RNAs) .m 687 to 1456 1 to 778       778/800
(97 %)
22 diff
(97.3 %id)
AW188942 serous papillary carcinoma, high grade, 2pooled tumors, uterus .m 1270 to 1475 206 to 1   tiling clone,   206/206
(100 %)
1 diff
(99.6 %id)
AW873689 adrenal gland, neuroblastoma .m 1275 to 1475 203 to 3       201/203
(99 %)
0 diff
(100 %id)
DA064859 cerebellum .n 1 to 568 2 to 569   tiling clone, capped   568/568
(100 %)
3 diff
(99.5 %id)
DB297218 cerebellum .n 5133 to 5663 532 to 1   tiling clone,   532/532
(100 %)
4 diff
(99.3 %id)
AK296424 thalamus .o 1 to 1033 2 to 1034 exact tiling clone,   1034/1034
(100 %)
2 diff
(99.9 %id)
TI_57244441   .o 116 to 890 24 to 796 L188G F189L Y190C V191L     773/796
(97 %)
18 diff
(97.8 %id)
BI915915 brain .o 121 to 890 1 to 768 L188G F189L Y190C V191L     768/768
(100 %)
12 diff
(98.5 %id)
AV697302 hepatocellular carcinoma .o 725 to 1123 1 to 394   tiling clone,   394/395
(99 %)
7 diff
(98.3 %id)
AV699410 hepatocellular carcinoma .o 5928 to 6551 624 to 1   tiling clone,   624/647
(96 %)
9 diff
(98.7 %id)
AB209850 aorta endothelial cell .p 1 to 7728 1 to 7728 exact tiling clone,   7728/7728
(100 %)
2 diff
(100.0 %id)
AW601634 breast .p 1418 to 2128 715 to 9       707/743
(95 %)
5 diff
(99.4 %id)
DC336004 hippocampus .p 1421 to 2017 1 to 597       597/597
(100 %)
1 diff
(99.9 %id)
AW601633 breast .p 1428 to 2075 660 to 12       649/661
(98 %)
1 diff
(99.9 %id)
AA778593   .p 1517 to 1917 401 to 1       401/401
(100 %)
0 diff
(100 %id)
DC346517 tongue, tumor tissue .p 1661 to 2237 1 to 577       577/577
(100 %)
0 diff
(100 %id)
CU452751 epidermis .p 1806 to 2478 14 to 686       673/686
(98 %)
7 diff
(99.0 %id)
BX472305   .p 2118 to 2697 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA329721 hippocampus .p 2205 to 2764 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA941538 Spleen .p 2206 to 2813 2 to 609   capped   608/608
(100 %)
1 diff
(99.9 %id)
CU444192 epidermis .p 2217 to 3046 847 to 18     Submitted on the opposite strand 830/847
(97 %)
2 diff
(99.8 %id)
DA482415   .p 2228 to 2807 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
CU454738 epidermis .p 2349 to 3046 715 to 18     Submitted on the opposite strand 698/715
(97 %)
1 diff
(99.9 %id)
DB060175 testis .p 2458 to 2986 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
CU449330 epidermis .p 2507 to 3046 557 to 18     Submitted on the opposite strand 540/557
(96 %)
2 diff
(99.7 %id)
CU451138 epidermis .p 2550 to 3046 513 to 18     Submitted on the opposite strand 496/513
(96 %)
8 diff
(98.5 %id)
AV751395 Pituitary .p 2550 to 2955 1 to 407       407/411
(99 %)
2 diff
(99.6 %id)
DB049879 testis .p 3513 to 4074 2 to 566   capped   565/572
(98 %)
6 diff
(99.0 %id)
AA326345 brain, cerebellum .p 3666 to 4055 1 to 391       391/391
(100 %)
2 diff
(99.5 %id)
AW964951   .p 3667 to 4181 1 to 515       515/515
(100 %)
3 diff
(99.5 %id)
BQ722837 sympathetic trunk .p 3845 to 4589 1 to 755   tiling clone,   755/891
(84 %)
16 diff
(98.3 %id)
DA949379 Spleen .p 4696 to 5256 2 to 562   tiling clone, capped   561/561
(100 %)
1 diff
(99.9 %id)
DB219558 trachea .p 5081 to 5628 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA101923 cerebellum .p 5160 to 5724 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA808612 brain .p 5336 to 5899 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
CV420646 lung_tumor .p 5348 to 5705 1 to 367       367/368
(99 %)
12 diff
(96.8 %id)
CD657578 Embryonic Stem cells .p 5423 to 6236 55 to 860       806/886
(90 %)
20 diff
(97.8 %id)
DB150286 thymus .p 5718 to 6271 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BF880221 lung_tumor .p 6457 to 6805 350 to 3     Submitted on the opposite strand 348/350
(99 %)
0 diff
(100 %id)
BJ993058 hepatoblastoma .p 6526 to 6928 1 to 403       403/403
(100 %)
0 diff
(100 %id)
BG181424   .q 1 to 777 6 to 780 K17E M178* tiling clone,   780/780
(100 %)
14 diff
(98.3 %id)
BX386797   .r 1 to 766 1 to 768   tiling clone,   768/865
(88 %)
16 diff
(98.2 %id)
BQ892419 sympathetic trunk .r 123 to 944 1 to 829 exact tiling clone,   827/938
(88 %)
19 diff
(98.0 %id)
BX386796   .r 1053 to 2062 1006 to 1   tiling clone,   1006/1010
(99 %)
15 diff
(98.6 %id)
BX110303 liver and spleen .r 1114 to 1865 1 to 751   tiling clone,   751/751
(100 %)
3 diff
(99.7 %id)
DW443235 Liver .r 1434 to 1646 17 to 231       215/231
(93 %)
11 diff
(95.3 %id)
DW467603 Liver .r 1434 to 1762 17 to 345       329/345
(95 %)
9 diff
(97.4 %id)
DB451297 testis .s 1 to 477 2 to 478   tiling clone,   478/479
(99 %)
4 diff
(99.2 %id)
DC410350 thymus .s 78 to 671 1 to 594   tiling clone,   594/594
(100 %)
3 diff
(99.5 %id)
AW363045 colon .t 1 to 555 1 to 555 G109X A128X tiling clone,   555/555
(100 %)
5 diff
(99.1 %id)
BP301363   .u 1 to 583 1 to 582 F128X T141N L143A T144Y P145A ... tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
BX441247 brain, fetal brain .va 1 to 893 1 to 890   tiling clone,   890/895
(99 %)
5 diff
(99.5 %id)
BX447379 brain, fetal brain .va 1 to 1147 1 to 1146       1146/1154
(99 %)
13 diff
(98.9 %id)
BX451470 brain, fetal brain .va 765 to 1534 1 to 768   tiling clone,   768/827
(92 %)
21 diff
(97.5 %id)
BX451471 brain, fetal brain .va 775 to 1578 17 to 824   tiling clone,   808/826
(97 %)
17 diff
(98.0 %id)
DR759894 embryonic stem .va 1490 to 2106 1 to 617   tiling clone,   617/617
(100 %)
2 diff
(99.7 %id)
BX447378 brain, fetal brain .va 1860 to 2592 871 to 132   tiling clone,   740/900
(82 %)
0 diff
(100 %id)
BF931151 nervous_tumor .va 2048 to 2475 433 to 6     Submitted on the opposite strand 428/434
(98 %)
11 diff
(97.5 %id)
BQ272033 Pancreas, Purified pancreatic islet .va 2049 to 2514 1 to 466   tiling clone, fully sequenced,   466/466
(100 %)
4 diff
(99.2 %id)
BQ271708 Pancreas, Purified pancreatic islet .va 2484 to 2843 360 to 1   tiling clone, fully sequenced,   360/360
(100 %)
5 diff
(98.7 %id)
AV651558 corresponding non cancerous liver tissue .va 2637 to 3012 1 to 376   tiling clone, Submitted on the opposite strand 376/376
(100 %)
5 diff
(98.7 %id)
AV651561 corresponding non cancerous liver tissue .va 2637 to 3012 1 to 376     Submitted on the opposite strand 376/384
(97 %)
6 diff
(98.5 %id)
CB050254 Prostate .va 2864 to 3550 10 to 696 K111X E139G F140I E141* tiling clone,   687/696
(98 %)
10 diff
(98.6 %id)
DA593682 lung .vb 1 to 561 2 to 562   tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
BQ072336 pooled lung and spleen .vb 717 to 1435 66 to 796   tiling clone,   731/1193
(61 %)
23 diff
(98.1 %id)
BM511113 insulinoma, Pancreas .vb 804 to 1376 1 to 573   tiling clone,   573/573
(100 %)
6 diff
(99.0 %id)
AA007210 whole brain .vb 1411 to 1697 1 to 288   tiling clone,   288/288
(100 %)
3 diff
(99.0 %id)
CB139752 Liver .vb 1459 to 1996 1 to 539       539/539
(100 %)
3 diff
(99.5 %id)
CA440352 lung, Lung Focal Fibrosis .vb 1595 to 2170 13 to 588   tiling clone, Submitted on the opposite strand 576/588
(97 %)
6 diff
(99.0 %id)
H83170 liver and spleen .vb 1670 to 2116 1 to 459       459/464
(98 %)
16 diff
(96.6 %id)
CN401106 embryonic stem cells, cell lines H1, H7, andH9 .vb 1699 to 2499 1 to 797       797/797
(100 %)
8 diff
(99.0 %id)
FN061136 breast carcinoma .vb 1990 to 2080 92 to 1     Submitted on the opposite strand 92/92
(100 %)
1 diff
(99.0 %id)
AA478823.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vb 2028 to 2547 1 to 519   tiling clone, also hits gene MAF 519/538
(96 %)
32 diff
(94.1 %id)
BF887919 testis_normal .vb 2088 to 2230 11 to 147       137/152
(90 %)
9 diff
(94.1 %id)
FN111546 breast carcinoma .vb 2129 to 2236 107 to 1     Submitted on the opposite strand 107/107
(100 %)
1 diff
(99.1 %id)
AV747506 Pituitary .vb 2164 to 2646 1 to 467       467/544
(85 %)
12 diff
(97.8 %id)
BM510860 insulinoma, Pancreas .vb 2206 to 2823 633 to 16 exact tiling clone, AAA   618/618
(100 %)
1 diff
(99.9 %id)
DB319635 lung .vb 2284 to 2823 540 to 1 L17X tiling clone,   540/540
(100 %)
1 diff
(99.9 %id)
DA114437 cerebellum .vc 1 to 556 2 to 557   tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
AK095082 hippocampus .vc 283 to 3498 1 to 3216 exact tiling clone, available from FLJ,   3216/3216
(100 %)
4 diff
(99.9 %id)
DA307519 hippocampus .vc 284 to 871 2 to 590   capped   589/589
(100 %)
3 diff
(99.5 %id)
DB308319 hippocampus .vc 2968 to 3498 532 to 1       532/532
(100 %)
2 diff
(99.7 %id)
BF341246 brain, glioblastoma with EGFR amplification .vd 1 to 697 1 to 691 C25A I26S E27K M28C Y29T ... tiling clone,   691/691
(100 %)
8 diff
(98.9 %id)
W02879 melanocyte .vd 76 to 482 1 to 411   tiling clone, fully sequenced,   411/411
(100 %)
0 diff
(100 %id)
N45551 multiple sclerosis lesions .vd 102 to 678 1 to 591 I26H E27R M28N Y29V I30H ...     591/591
(100 %)
16 diff
(97.3 %id)
N74512 melanocyte .vd 452 to 891 444 to 1   tiling clone, fully sequenced,   444/444
(100 %)
7 diff
(98.5 %id)
BE972644 testis .ve 1 to 307 1 to 306 L43C Q44S W45G D46M V47L ... tiling clone, AAA   518/734
(70 %)
17 diff
(97.7 %id)
DB229961 trachea .vf 1 to 601 2 to 605 exact tiling clone, to resequence, capped   604/604
(100 %)
3 diff
(99.6 %id)
BQ028188 mixed .vf 215 to 787 592 to 19   tiling clone, AAA   574/574
(100 %)
3 diff
(99.5 %id)
DB349952 trachea .vf 1362 to 1917 558 to 1   tiling clone, to resequence,   558/558
(100 %)
3 diff
(99.5 %id)
N78265 liver and spleen .vg 1 to 374 1 to 377   tiling clone,   377/522
(72 %)
13 diff
(97.6 %id)
BQ888235 sympathetic trunk .vg 150 to 1043 1 to 891 M53N N54E E55* tiling clone, AAA   891/891
(100 %)
22 diff
(97.6 %id)
N59525 liver and spleen .vg 645 to 995 356 to 7   tiling clone,   350/356
(98 %)
3 diff
(99.2 %id)
TI_149294618   .vh 1 to 880 933 to 62 exact tiling clone, AAA   872/989
(88 %)
15 diff
(98.5 %id)
BU683268 lung .vh 151 to 880 748 to 19 exact AAA   730/730
(100 %)
0 diff
(100 %id)
AI864660 pooled .vh 282 to 880 609 to 10 exact     600/609
(98 %)
3 diff
(99.6 %id)
BF590143 pooled .vh 354 to 880 539 to 12 D9E Y10L F11L H12P T13H ... AAA   528/531
(99 %)
4 diff
(99.3 %id)
AI309243 adenocarcinoma, colon .vh 420 to 880 463 to 3 H12T     461/463
(99 %)
2 diff
(99.6 %id)
BF436172 pooled .vh 501 to 880 390 to 11   AAA   380/419
(90 %)
6 diff
(98.6 %id)
FN050482 breast carcinoma .vh 519 to 626 108 to 1     Submitted on the opposite strand 108/108
(100 %)
0 diff
(100 %id)
BF990579 placenta_normal Gene CDC16, variant not shown         This clone was ignored    
BP204902 coronary artery Gene CDC16, variant not shown         This clone was ignored    
AA007208 whole brain Gene CDC16, variant not shown         This clone was ignored    
AA007209 whole brain Gene CDC16, variant not shown         This clone was ignored    
N36419 melanocyte Gene CDC16, variant not shown       AAA Suspected internal deletion, this clone was ignored    
N44294 melanocyte Gene CDC16, variant not shown         Suspected internal deletion, this clone was ignored    
AI129866 uterus Gene CDC16, variant not shown         This clone was ignored    
DB135671 thymus Gene CDC16, variant not shown       capped This clone was ignored    
DB344974 thymus Gene CDC16, variant not shown         This clone was ignored    
DB289741 uterus Gene CDC16, variant not shown       capped This clone was ignored    
DB352966 uterus Gene CDC16, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI